Search Results for: us stem cell

Harvard Predicts Fat Burning Stem Cell Pill To Replace Exercise

Moisan-et-al

A hot topic in biomedical sciences is converting white “bad” fat into brown “good” fat. The latter type of adipose is viewed more positively because it seems to be associated with a relatively metabolically more active, leaner state. Could we somehow convert white adipose to brown adipose and in so doing have a beneficial effect […]

Harvard Predicts Fat Burning Stem Cell Pill To Replace Exercise Read More »

STAP cells Voted as the Stem Cell Story of the Year for 2014

Stem-Cell-Story-of-2014

When I asked the readers of this blog what they felt was the biggest stem cell story of 2014 in a poll, they overwhelmingly picked the STAP cell scandal. For background on STAP you can toggle through the many STAP cell pieces on this blog here, see a STAP timeline, and a STAP image gallery. Basically,

STAP cells Voted as the Stem Cell Story of the Year for 2014 Read More »

Did NBC News Err On Key Part of Their Stem Cell Report?

Steven-Gitt-Nancy-Snyderman

NBC News did a big on-line story and even a NBC Nightly News Segment on dubious stem cell therapies on Friday. Normally a national news story on the problem of the mushrooming stem cell clinics selling unapproved “treatments” would be a positive development, but this otherwise very nicely done story might have a major error that could confuse millions

Did NBC News Err On Key Part of Their Stem Cell Report? Read More »

About Us, The Niche and Knoepfler Lab

Knoepfler-Lab-2019

The Niche is the top, most authoritative stem cell and regenerative medicine blog on the web. It’s the only one to our knowledge written mostly by a professor. Professor Paul Knoepfler of UC Davis School of Medicine, an internationally respected stem cell biologist and educator, runs The Niche. Knoepfler is an advocate of rigorous evidence-based

About Us, The Niche and Knoepfler Lab Read More »

FDA on Key Stem Cell Regulatory Issues & Its Own Research

FDA3

It’s been a seemingly rather quiet year on the FDA regulatory front in the US when it comes to direct-to-consumer stem cell interventions even as the number of dubious stem cell clinics continues to skyrocket. I requested an interview with the FDA to cover the key pressing issues in this arena. I want to thank

FDA on Key Stem Cell Regulatory Issues & Its Own Research Read More »